Evaluation of pharmacologic agents for restraint in cystometry in the dog and cat.
D000075:Acepromazine / Q000494:pharmacology; D000388:Air; D000758:Anesthesia / Q000662:veterinary*; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D002415:Cats / Q000502:physiology*; D004285:Dogs / Q000502:physiology*; D004329:Droperidol / Q000494:pharmacology; D005260:Female; D005283:Fentanyl / Q000494:pharmacology; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006221:Halothane / Q000494:pharmacology; D007649:Ketamine / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010424:Pentobarbital / Q000494:pharmacology; D011312:Pressure; D012018:Reflex / Q000187:drug effects; D013840:Thiamylal / Q000494:pharmacology; D013843:Thiazines / Q000494:pharmacology*; D014159:Transducers; D001743:Urinary Bladder / Q000187:drug effects / Q000502:physiology*; D014546:Urinary Catheterization; D014992:Xylenes / Q000494:pharmacology
D000814:Aniline Compounds; D013843:Thiazines; D014992:Xylenes; D013840:Thiamylal; D000075:Acepromazine; D007649:Ketamine; D010424:Pentobarbital; D004329:Droperidol; D005703:Gallamine Triethiodide; D005283:Fentanyl; D006221:Halothane